DDNDDN
Opportunities

HelixForge Therapeutics

DiscoverActiveEMEAHybrid
Genomic analysis turnaround & dataset growth
€450.0K
17
Qualification
0
Solution Fit
0
Discovery
0
Value Conf.
0
Tech Confidence
Industry
Healthcare & Life Sciences
Country / Region
Switzerland / EMEA
Close Date
—
Sales Owner
—
SE Owner
—
Probability (SE judgement)
30%
Quote Status
—
Contract Value
€900.0K
Critical qualification gaps
Economic Buyer (Unknown)Champion (Unknown)Decision Criteria (Weak)Decision Process (Unknown)
Next Action
Complete data-path investigation workshop
Owner: Marco Rossi · Due: 2026-12-15
Business Challenge & Consequences

Genomic analysis turnaround growing with dataset size; data path not yet characterised.

Slower discovery cycles; analysis backlog.

Desired Business Outcomes

Faster genomic pipeline turnaround; predictable performance as data grows.

Compelling Event

Sequencing capacity expansion planned

Workloads & Solution Direction
Research/genomics pipelinesAnalytics and data engineering
Primary Direction
inference-context
Application / Framework
—
Current Environment
Compute / GPU
Mixed CPU + 8× A100
GPU / Node Counts
8× A100
Storage / Data Platform
NFS + object store
Network
100Gb Ethernet
Workload Characteristics
Data Capacity & Growth
—
Active Working Set
20 TB
Current Performance
48h per pipeline batch
Target Performance
24h per pipeline batch
Access Patterns
Mixed file/object, metadata-light
Read/Write, Concurrency
—
Required Protocols
NFS, S3
Checkpoint / Restart
—
Availability / Recovery
—
Security / Residency
—
Known Technical Blockers
Data path bottleneck not yet isolated
Success Criteria (agreed)
Not yet agreed
Competition & Alternatives
Competitors
Cloud object storage
Alternatives
Expand NFS, do nothing